SEGAL LLOYD MITCHELL (President and CEO) received a stock award from REPARE THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/1/2023ACC: 0001209191-23-006062
Officer· President and CEO
Since Jun 2020
+422.75K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
422.75K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+78.55K
Price / share
—
Trade value
—
% of position
1282.0%
1/30/2023
6.13K→84.68K
Total
Net shares
+78.55K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 1/30/2023 | A · Award | +78.55K | — | — | 1282.0% | 6.13K | 84.68K |
| Total | +78.55K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Shares
344.20K shares
Shares
+344.20K
Strike price
12.42
Held after
344.20K
Exercisable
—
1/30/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Shares344.20K shares | 1/30/2023 | A · Award | +344.20K | 12.42 | — | 344.20K |
Non-Derivative Holdings (Post-Transaction)1
Common Shares
IndirectShares owned94.47K
Total
94.47K indirect94.47K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 94.47K | Indirect |
| Total | 94.47K | 94.47K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported